Volume 75, Number 7, August 17, 2010
About this course
- Released: 08/16/2010
- Expires: 08/17/2012
Learning Objectives:
Upon completion of the article by Lion-Francois, the participant should be able to:
• Summarize the clinical characteristics of the patients with neonatal episodic laryngospasm due to de novo SCN4A mutations.
• Describe the muscular appearance, after several months, of the infants with this condition.
• Describe the treatment of patients with severe neonatal episodic laryngospasm due to de novo SCN4A mutations
Core Competencies:
The article by Lion-Francois covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Garcia, the participant should be able to:
• Discuss the life cycle of the organism that causes neurocysticercosis.
• Describe the pathogenesis of neurocysticercosis.
• Discuss the authors' hypothesis regarding the pathophysiology of the solitary cysticercal granuloma.
Core Competencies:
The article by Garcia covers the following core competency:
• Medical Knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
